3d structure visualization tools biovia discovery studios (Accelrys)
90
Structured Review
Accelrys
3d structure visualization tools biovia discovery studios
3d Structure Visualization Tools Biovia Discovery Studios, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+structure+visualization+tools+biovia+discovery+studios/3d+structure+visualization+tools+biovia+discovery+studios/10__1016_slash_j__molstruc__2023__135556-81-16-16
Average 90 stars, based on 1 article reviews
3d Structure Visualization Tools Biovia Discovery Studios, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+structure+visualization+tools+biovia+discovery+studios/3d+structure+visualization+tools+biovia+discovery+studios/10__1016_slash_j__molstruc__2023__135556-81-16-16
Average 90 stars, based on 1 article reviews
3d structure visualization tools biovia discovery studios - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Green Synthesis, Antimycobacterial Evaluation and Molecular Docking Studies of Novel 2,3-Dihydro-1H-pyrazol-4-ylnaphthalene-1,4-diones Article Snippet: A novel series of 2,3-dihydro-1H-pyrazol-4-ylnaphthalene-1,4-diones is synthesized via one-pot, multi-component condensation of ethyl acetoacetate, 4-(trifluoromethyl)phenylhydrazine, aromatic aldehydes and 7-fluoro2-hydroxynaphthalene-1,4‐dione in aqueous p-toluenesulfonic acid (15 mol%) at 100 C. The synthesized compounds (5a-j) were evaluated for their in vitro antimycobacterial efficacy against drug-sensitive and isoniazid-resistant Mycobacterium tuberculosis (Mtb) H37Rv strains using the broth based method.. All compounds displayed good to better antimycobacterial activity with MIC values ranging from 0.49 to 5.16 μM.. Compound 5i (MIC = 0.49±0.08 μM) demonstrated equivalent antimycobacterial activity as that of the reference drug isoniazid (MIC = 0.35±0.06 μM). |